SEC Filings
Fuller & Thaler Holds 5.33% Of Prestige Consumer Healthcare In Passive Stake
The investment adviser reported 2,527,139.37 shares as of September 30 and certified that it does not seek to influence control.
Prestige Consumer Healthcare (PBH) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
SEC Filings
The investment adviser reported 2,527,139.37 shares as of September 30 and certified that it does not seek to influence control.
Earnings
The CEO called Clear Eyes "the other 1.5%" of sales, but zero safety stock and production problems forced a lower full-year forecast.
Deals
A valuation allowance and $2.1 billion of debt cut reported earnings to $0.53 a share, while the adjusted figure rose to $1.13.
Earnings
The company also lowered its adjusted EPS forecast to $4.48 to $4.55 on variable Clear Eyes output at its Pillar5 plant.